Medicine guide

FLUOROURACIL INJECTION

As listed in the register: FLUOROURACIL INJECTION

500 mg · solution

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Fluorouracil
Made by
Generic Medical Partners Inc

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01BC02

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (Fluorouracil). It describes the substance, not this exact product.

Fluorouracil is a nucleoside metabolic inhibitor that interferes with the synthesis of deoxyribonucleic acid (DNA) and to a lesser extent inhibits the formation of ribonucleic acid (RNA); these affect rapidly growing cells and may lead to cell death.

Fluorouracil is converted to three main active metabolites: 5-fluoro-2′-deoxyuridine-5′-monophosphate (FdUMP), 5-fluorouridine-5′- triphosphate (FUTP) and 5-fluoro-2′-deoxyuridine-5′-triphosphate (FdUTP).

Half-life8–20 min
Mostly cleared after≈ 1.2 hfive half-lives — our arithmetic
How the body breaks it down

The remaining percentage of the administered dose is metabolized, primarily in the liver.

How it leaves the body

Following bolus intravenous injection, 5 – 20 % of the parent drug is excreted unchanged in the urine in six hours.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-15

Safety of the active substance

From the US prescribing label for the same active substance (Fluorouracil). It describes the substance, not this exact product.

Serious warning

WARNING: SERIOUS ADVERSE REACTIONS OR DEATH IN PATIENTS WITH COMPLETE DPD DEFICIENCY Increased Risk of Serious Adverse Reactions or Death in Patients with Complete DPD Deficiency Test patients for genetic variants of DPYD prior to initiating fluorouracil unless immediate treatment is necessary.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byGeneric Medical Partners Inc
Active substanceFluorouracil
Used inCancer treatments and immune-system medicines
Strength500 mg
Formsolution
ClassificationL01BC02 · Cancer treatments and immune-system medicines
Routeintravenous
Dispensing (as stated by the register)PRESCRIPTION
StatusApproved
MarketedNo — authorised but not currently marketed, according to the register
DIN02476738
DPD drug code96757

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Other strengths and forms

7 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.